FastOMOP: A Foundational Architecture for Reliable Agentic Real-World Evidence Generation on OMOP CDM data
On the map: LLM agents and tool use → Medical and scientific domain agents
Abstract (arXiv)
The Observational Medical Outcomes Partnership Common Data Model (OMOP CDM), maintained by the Observational Health Data Sciences and Informatics (OHDSI) collaboration, enabled the harmonisation of electronic health records data of nearly one billion patients in 83 countries. Yet generating real-world evidence (RWE) from these repositories remains a manual process requiring clinical, epidemiological and technical expertise. LLMs and multi-agent systems have shown promise for clinical tasks, but RWE automation exposes a fundamental challenge: agentic systems introduce emergent behaviours, coordination failures and safety risks that existing approaches fail to govern. No infrastructure exists to ensure agentic RWE generation is flexible, safe and auditable across the lifecycle. We introduce FastOMOP, an open-source multi-agent architecture that addresses this gap by separating three infrastructure layers, governance, observability and orchestration, from pluggable agent-teams. Governance is enforced at the process boundary through deterministic validation independent of agent reasoning, ensuring no compromised or hallucinating agent can bypass safety controls. Agent teams for phenotyping, study design and statistical analysis inherit these guarantees through controlled tool exposure. We validated FastOMOP using a natural-language-to-SQL agent team across three OMOP CDM datasets: synthetic data from Synthea, MIMIC-IV and a real-world NHS dataset from Lancashire Teaching Hospitals (IDRIL). FastOMOP achieved reliability scores of 0.84-0.94 with perfect adversarial and out-of-scope block rates, demonstrating process-boundary governance delivers safety guarantees independent of model choice. These results indicate that the reliability gap in RWE deployment is architectural rather than model capability, and establish FastOMOP as a governed architecture for progressive RWE automation.
Key facts. No citing papers in the map yet (data through 14 Oct 2026). Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use. Builds on 4 of its 32 references that are in the map. First posted on arXiv 27 Apr 2026.
Builds on
4 of 32 references.
Closest ancestors · 1
Same direction, newest first
- 2025Demo: Healthcare Agent Orchestrator (HAO) for Patient Summarization in Molecular Tumor Boards8 Sep
Other references · 3
Built on by
Not cited yet.
Similar, not cited
Close in wording, no citation either way
- 2026Can LLM Agents Generate Real-World Evidence? Evaluating Observational Studies in Medical Databases
- 2025An Agentic Model Context Protocol Framework for Medical Concept Standardization
- 2026Ascent: An Agentic System over the Model Context Protocol for Real-World Clinical Data Analysis
- 2026Small Agent Group is the Future of Digital Health
- 2025PublicAgent: Multi-Agent Design Principles From an LLM-Based Open Data Analysis Framework
- 2026MDIA: A Multi-Agent Diagnostic Intelligence Pipeline on HealthBench Professional
- 2026GxP-Agent: Process-DAG Topology for Reliable Clinical Trial Programming with LLM Agents
- 2026MedHarnessBench: A Unified Benchmark for Healthcare Agent Evaluation